Melanoma Clinical Trials in Palo Alto, California
2 recruitingPalo Alto, California
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ovarian CarcinomaColorectal CarcinomaMelanoma+19 more
Children's Oncology Group147 enrolled21 locationsNCT04851119
Recruiting
Phase 2
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
MelanomaBrain Metastases
Stanford University60 enrolled1 locationNCT06712927